diclazepam
Selected indexed studies
- Overdose from designer benzodiazepine Diclazepam. (QJM, 2020) [PMID:31593281]
- Discriminative stimulus and reinforcing effects of diclazepam in rodents. (Pharmacol Biochem Behav, 2024) [PMID:38016594]
- Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine. (Forensic Sci Int, 2019) [PMID:31546164]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Overdose from designer benzodiazepine Diclazepam. (2020) pubmed
- Discriminative stimulus and reinforcing effects of diclazepam in rodents. (2024) pubmed
- Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine. (2019) pubmed
- Highly Efficient Dual-Color Luminophores for Sensitive and Selective Detection of Diclazepam Based on MOF/COF Bi-Mesoporous Composites. (2023) pubmed
- Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. (2014) pubmed
- Metabolic interactions of benzodiazepines with oxycodone ex vivo and toxicity depending on usage patterns in an animal model. (2023) pubmed
- [Identification of New Designer Benzodiazepine Diclazepam in Drug Facilitated Sexual Assault]. (2018) pubmed
- A Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data. (2018) pubmed
- Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances-Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam-in the UK. (2018) pubmed
- ELISA Detection of Phenazepam, Etizolam, Pyrazolam, Flubromazepam, Diclazepam and Delorazepam in Blood Using Immunalysis® Benzodiazepine Kit. (2016) pubmed